Tranexamic acid in trauma patients in the emergency department: systematic review and meta-analysis.
Emergencias · 2019-01-01 · Meta-analysis
Abstract
OBJECTIVES: The aim of this systematic review and meta-analysis was to evaluate the efficacy (mortality and functional status) and safety of emergency department (ED) use of tranexamic acid (TXA) in patients with severe trauma. MATERIAL AND METHODS: MEDLINE, Embase, the Cochrane Library, the Web of Science, and ClinicalTrials.gov were searched to find relevant clinical trials published between January 1, 2008, and 1 August, 2018. The selected trials included trauma patients who received infusions of TXA within 8 hours. We extracted patient-related clinical variables and treatment variables. The main outcomes were mortality and functional status. RESULTS: Five clinical trials were included in the systematic review. Four of them (20 697 patients) were included in the metaanalysis. We found that TXA versus placebo was associated with lower mortality (OR, 0.89 [95% CI, 0.83-0.96]; P = .004; 2 = 0%) and better functional status (OR, 0.60 [95% CI, 0.39-0.94]; P = .02; I2 = 0%). However, intensive care unit stays were longer in patients administered TXA (mean difference, 2.55 days [95% CI, 0.04-5.06 days]; P = .05; I2 = 0%). CONCLUSION: ED infusion of TXA decreases mortality after severe trauma and improves patients' functional status.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Haemostatics · Tranexamic acid · Mortality & survival · Quality of life & function
Related articles
- Clinical outcomes of hemostatic interventions in patients with traumatic injury: A systematic review of randomized controlled trials. (J Trauma Acute Care Surg, 2026)
- Prehospital tranexamic acid in trauma patients: a systematic review and meta-analysis of randomized controlled trials. (Front Med (Lausanne), 2023)
- Systemic hemostatic agents initiated in trauma patients in the pre-hospital setting: a systematic review. (Eur J Trauma Emerg Surg, 2023)
- Prehospital Tranexamic Acid for Severe Trauma. (N Engl J Med, 2023)
- Protocol for a multicentre prehospital randomised controlled trial investigating tranexamic acid in severe trauma: the PATCH-Trauma trial. (BMJ Open, 2021)
- Association between coagulation biomarkers, intracranial hemorrhage types, and tranexamic acid treatments in early traumatic brain injury. (J Trauma Acute Care Surg, 2025)